BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Signaling lymphocytic activation molecule family 3 (SLAMF3; LY9)

August 18, 2016 7:00 AM UTC

Patient sample studies suggest agonizing SLAMF3 could help treat systemic lupus erythematosus (SLE). Reduced interleukin-2 (IL-2)-induced proliferation in activated, naïve CD4+ T cells is a marker of ...